"tyrosine phosphorylation" trang 12 - tải miễn phí từ tailieunhanh
Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells

Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells
10    24    1
Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression

Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression
19    48    1
Erlotinib treatment after platinum-based therapy in elderly patients with non-smallcell lung cancer in routine clinical practice – results from the ElderTac study

Erlotinib treatment after platinum-based therapy in elderly patients with non-smallcell lung cancer in routine clinical practice – results from the ElderTac study
11    42    1
Apatinib for advanced sarcoma: Results from multiple institutions’ off-label use in China

Apatinib for advanced sarcoma: Results from multiple institutions’ off-label use in China
10    60    1
Screening of antimicrobial spectrum of Brevibacillus sp. isolated from dairy environment

Screening of antimicrobial spectrum of Brevibacillus sp. isolated from dairy environment
9    50    1
Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells
13    37    1
Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study

Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study
8    59    1
Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution
10    33    1
Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels

Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels
3    24    1
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
12    45    1
Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: Initial experience of molecularly targeted therapy

Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: Initial experience of molecularly targeted therapy
9    55    1
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
9    66    1
The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study
12    26    1
Case report: Primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation

Case report: Primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation
4    42    1
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
13    53    1
Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery
8    41    1
SoLAT (Sorafenib Lenvatinib alternating treatment): A new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer

SoLAT (Sorafenib Lenvatinib alternating treatment): A new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
12    72    1
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study

Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
6    47    1
Combining genomic analyses with tumourderived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma

Combining genomic analyses with tumourderived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma
9    55    1
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial
7    38    1